dr. grisham on frontline treatment for low-grade serous ovarian cancer
Published 5 years ago • 1.6K plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:59
dr. grisham on mek inhibition in low-grade serous ovarian cancer
-
7:44
frontline treatments in ovarian cancer
-
0:24
what’s the latest in low-grade serous ovarian cancer?
-
26:02
updates in ovarian cancer: frontline maintenance
-
4:53
dr robb hollis: ‘towards new therapies for low grade serous ovarian cancer.’
-
8:26
the impact of paola-1 on frontline treatment of ovarian cancer
-
9:03
low-grade serous ovarian cancer
-
13:10
research update on recurrent low-grade serous ovarian cancer
-
1:18
dr. sabbatini on frontline treatment of newly diagnosed ovarian cancer
-
2:17
is trametinib a new standard for low-grade serous ovarian cancer?
-
1:15
dr. berger on frontline treatment options in newly diagnosed advanced ovarian cancer
-
6:10
dr. grisham discusses start of phase 2 trial on investigational raf/mek inhibitor in ovarian cancer
-
43:28
management challenges of low grade serous ovarian/peritoneal cancer - david gershenson
-
7:57
duration of frontline therapy in ovarian cancer
-
55:39
latest updates in low grade serous ovarian cancer treatment and research
-
3:21
need for frontline comparison trials in ovarian cancer
-
6:03
gog-0218: frontline bevacizumab in ovarian cancer
-
8:59
cytoreductive surgery and adjuvant hormonal therapy for low grade serous ovarian carcinoma
-
1:13
what is low-grade serous ovarian cancer (lgsoc)? | let’s talk about lgsoc